Arizona senators voted to approve A Public Appropriations Act 2023-2024 on May 10. Within the Act appropriations are many Funding proposals from the governor’s officewhich includes everything from Alzheimer’s research ($4.1 million), a newborn screening program ($12 million), and the Arizona Nurse Education investment program ($15 million), but also includes $5 million earmarked for Psilocybin Research.
health care bill. SB-1726 / HB-2816I recently received a hearing on May 10th as well, which shows what $5 million in research will go toward “research grants for whole mushroom psilocybin, Phase I, Phase II and 41 Phase III clinical trials that may be approved by 42 United States.” FDA…” The bill cites a number of medical conditions, including post-traumatic stress disorder, prolonged COVID-19 symptoms, depression, anxiety disorders, and nine other conditions.
If passed, it would require the Department of Health Services to open applications for research, which would be granted no later than February 1 each year. The department will be limited to spending a maximum of 2% of funds for psilocybin grant research in each fiscal year.
Research topics will specifically include “veterans, first responders, frontline health care workers…and people from disadvantaged communities.”
Protections are also included for both grant recipients as well as any employees working on a study, stating that they “shall not be accused or prosecuted for possession of… psilocybin when the person is working on the clinical trial.”
An advisory board for psilocybin research will be tasked with administering the program to make “recommendations to the governor, the speaker of the House, the president of the senate and the department regarding narcotic-assisted treatment based on current federal and state research policy.” It will be made up of several key individuals, including a member with a federal license to study A narcotic is a licensed physician, an Army veteran, an Arizona law enforcement officer, and a professor or researcher who specializes in psychedelic studies.
On February 13, lawmakers unanimously passed the Various psilocybin research bill on the House Committee on Military Affairs and Public Safety, which would have awarded $30 million in grants to psilocybin researchers. Today, HB 2486 (Clinical Research; psilocybin; grants; appropriations) passed the MAPS committee by a vote of 15 to 0! Thank you to the brave, bipartisan legislators sponsoring this bill to study veterans and first responders! @tweet @tweet @tweet @tweet,” He said Dr. Sue Sisleyfamous for her research on cannabis and drugs. HB-2486 He has not received any further discussion as of this writing.
While cannabis studies continue to grow, so do the number of psilocybin research efforts. In February, city officials at Ferndale, Michigan It was voted to decriminalize mushrooms as well as other cannabinoids such as DMT and ayahuasca, and Utah Officials introduced the psilocybin bill. in March , nv Lawmakers introduced the psilocybin and MDMA research bill, and Missouri The House of Representatives approved the psilocybin research bill.
on May 10th Washington state Governor Jay Inslee signed a bill creating a psilocybin treatment pilot program, though he did so by partially vetoing specific sections. in the same day , Connecticut The House of Representatives approved a bill to decriminalize psilocybin.
Oregon is the oldest in terms of progress. Earlier this month, Oregon granted its first psilocybin service center license, after finalizing rules back in January. “This is a historic moment as psilocybin services will soon be available in Oregon, and we appreciate the strong commitment to customer safety and access as our service center doors prepare to open,” said Psilocybin Services Oregon Division Director. Angie Albee.
